EP2994137
TREATMENT OF CANCER WITH NALTREXONE
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
12.5.2014EP published:
14.12.2022EP application number:
14725506.1
EPO information:
European Patent Register
Max expiry date:
11.5.2034
Title in English:
TREATMENT OF CANCER WITH NALTREXONELanguage of the patent:
English
Timeline
Today
12.5.2014EP application
14.12.2022EP Publication
Owner
Name:
LDN Pharma LimitedAddress:
45 Gresham Street, London EC2V 7BG, GB
Inventor
Name:
DALGLEISH, AngusAddress:
London SW19 0RE, GB
Name:
ALLEN, RachelAddress:
London SW19 0RE, GB
Priority
Number:
201308440Date:
10.5.2013Country:
GB
Classification
Categories:
A61K 31/485, A61K 31/593, A61K 45/06, A61P 35/00, A61P 37/02